Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C
- 31 October 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 39 (4) , 606-613
- https://doi.org/10.1016/s0168-8278(03)00298-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis CJournal of Hepatology, 2001
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 UpdateJournal of Viral Hepatitis, 2001
- Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort StudyHepatology, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Hepatitis CThe Lancet, 1998
- Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trialsHepatology, 1997
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and DurationHepatology, 1996
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992